Genoray Co. Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: 0.057x

Genoray Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, Genoray Co. Ltd (122310) has a cash flow conversion efficiency ratio of 0.057x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.78 Billion ≈ $3.24 Million USD) by net assets (₩83.75 Billion ≈ $56.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Genoray Co. Ltd (2015–2025)

Cash flow conversion efficiency of Genoray Co. Ltd from 2015 to 2025. This chart illustrates how Genoray Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Genoray Co. Ltd stock quote for real-time trading data and today's change.

Genoray Co. Ltd Cash Flow Conversion Ratio Explained

Genoray Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Genoray Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Genoray Co. Ltd ranked by their cash flow conversion efficiency. Also see Genoray Co. Ltd (122310) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Aquarius Engines AM Ltd TA:AQUA	-32.231x
J.S.P. Property Public Company Limited BK:JSP	0.046x
PSQ Holdings Inc. NYSE:PSQH	-0.496x
Sc Engineering KO:023960	-0.308x
Barem Ambalaj Sanayi ve Ticaret a.s. IS:BARMA	0.232x
Eupe Corporation Bhd KLSE:6815	0.111x
Izostal SA WAR:IZS	-0.217x
Higgstec TWO:5220	0.008x

Annual Cash Flow Conversion Efficiency for Genoray Co. Ltd (2015–2025)

The table below shows the annual cash flow conversion efficiency of Genoray Co. Ltd from 2015 to 2025. Review 122310 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩83.75 Billion ≈ $56.76 Million	₩5.26 Billion ≈ $3.56 Million	0.063x	-59.38%
2024-12-31	₩85.89 Billion ≈ $58.21 Million	₩13.27 Billion ≈ $9.00 Million	0.155x	+315.37%
2023-12-31	₩95.53 Billion ≈ $64.74 Million	₩3.55 Billion ≈ $2.41 Million	0.037x	-77.94%
2022-12-31	₩87.96 Billion ≈ $59.61 Million	₩14.84 Billion ≈ $10.05 Million	0.169x	-13.58%
2021-12-31	₩78.82 Billion ≈ $53.41 Million	₩15.38 Billion ≈ $10.43 Million	0.195x	+52.63%
2020-12-31	₩66.53 Billion ≈ $45.08 Million	₩8.51 Billion ≈ $5.77 Million	0.128x	-28.49%
2019-12-31	₩59.59 Billion ≈ $40.38 Million	₩10.65 Billion ≈ $7.22 Million	0.179x	+16.67%
2018-12-31	₩44.97 Billion ≈ $30.48 Million	₩6.89 Billion ≈ $4.67 Million	0.153x	-16.72%
2017-12-31	₩24.30 Billion ≈ $16.47 Million	₩4.47 Billion ≈ $3.03 Million	0.184x	-21.57%
2016-12-31	₩14.80 Billion ≈ $10.03 Million	₩3.47 Billion ≈ $2.35 Million	0.235x	+26.88%
2015-12-31	₩11.35 Billion ≈ $7.69 Million	₩2.10 Billion ≈ $1.42 Million	0.185x	--

About Genoray Co. Ltd

KQ:122310 Korea Diagnostics & Research

Market Cap

$24.70 Million

₩36.44 Billion KRW

Market Cap Rank

#24257 Global

#1723 in Korea

Share Price

₩3000.00

Change (1 day)

-1.48%

52-Week Range

₩3000.00 - ₩4950.00

All Time High

₩11740.92